DARUNAVIR | A212493 | AMNEAL EU LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
JANSSEN PRODUCTS, L.P. et al v. AMNEAL PHARMACEUTICALS, LLC et al 3 patentsANDA 212493darunavir | D.N.J. | 2018-12-26 | Terminated 2019-05-02 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.27
per ea
Lowest NADAC/Unit
$1.18
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 60219114503DARUNAVIR 800 MG TABLET | $2.27 | EA | Generic | — | 2026-06-17 |
| 60219114406DARUNAVIR 600 MG TABLET | $1.18 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.